#	Pagina
attuale pagina	/open-h2020/projects/224809/index.html

Opendata, web and dolomites

HeatNMof SIGNED

Heating triggered drug release from nanometric inorganic-metal organic framework composites

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

HeatNMof project word cloud

Explore the words cloud of the HeatNMof project. It provides you a very rough idea of what is the project "HeatNMof" about.

heatnmof porous concerning inside photo intersectorial inorganic imaging administration biocompatibility magnetic nanoparticles biocompatible successful train characterization matters environment soundly heating potent triggered smart either insufficient upcoming generation materials versatile prime improvement platform biological body bench excellent exceptional additional drawbacks consequently toxicity domain drug reactions hyperthermia expertise thermal bioavailability nanocarrier material therapy training sound physicochemical platforms optoacoustic nanomaterials hybrid although networking cancer nanotechnology nanometric resonance society nanocarriers drugs metal releases societal efficient industrial routes antitumoral living scientists revolutionize payloads organic nanomedicine health release reproducibility multifunctional demand academic frameworks optimization interdisciplinary entities interaction

Project "HeatNMof" data sheet

The following table provides information about the project.

Coordinator	Fundacion IMDEA Energia Organization address address: AVENIDA RAMON DE LA SAGRA 3 city: MOSTOLES MADRID postcode: 28935 website: http://www.imdea.org/energia contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Total cost	3˙139˙408 €
EC max contribution	3˙139˙408 € (100%)
Programme	1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
Code Call	H2020-MSCA-ITN-2019
Funding Scheme	MSCA-ITN-ETN
Starting year	2020
Duration (year-month-day)	from 2020-03-01 to 2024-02-29

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	Fundacion IMDEA Energia Fundacion IMDEA Energia Organization address address: AVENIDA RAMON DE LA SAGRA 3 city: MOSTOLES MADRID postcode: 28935 website: http://www.imdea.org/energia contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MOSTOLES MADRID)	coordinator	501˙809.00
2	FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA Organization address address: VIA MOREGO 30 city: GENOVA postcode: 16163 website: www.iit.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (GENOVA)	participant	522˙999.00
3	IMMATERIAL LABS LTD IMMATERIAL LABS LTD Organization address address: SUITE 48 CAMBRIDGE INNOVATION CENTRE UNIT 23 CAMBRIDGE SCIENCE PARK MILTON ROAD city: CAMBRIDGE postcode: CB4 0EY website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (CAMBRIDGE)	participant	303˙172.00
4	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS Organization address address: RUE MICHEL ANGE 3 city: PARIS postcode: 75794 website: www.cnrs.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	274˙802.00
5	INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE Organization address address: AVENUE DE RANGUEIL 135 city: TOULOUSE postcode: 31077 website: www.insa-toulouse.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (TOULOUSE)	participant	274˙802.00
6	UNIVERSITEIT ANTWERPEN UNIVERSITEIT ANTWERPEN Organization address address: PRINSSTRAAT 13 city: ANTWERPEN postcode: 2000 website: www.ua.ac.be contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (ANTWERPEN)	participant	256˙320.00
7	UNIVERSITAET HAMBURG UNIVERSITAET HAMBURG Organization address address: MITTELWEG 177 city: HAMBURG postcode: 20148 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (HAMBURG)	participant	252˙788.00
8	ISERN PATENTES Y MARCAS M SL ISERN PATENTES Y MARCAS M SL Organization address address: PS DE LA CASTELLANA 115 1 DC city: MADRID postcode: 28001 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MADRID)	participant	250˙904.00
9	NANOSCALE BIOMAGNETICS SOCIEDAD LIMITADA NANOSCALE BIOMAGNETICS SOCIEDAD LIMITADA Organization address address: CALLE PANAMA 2, LOCAL 1 city: ZARAGOZA postcode: 50012 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (ZARAGOZA)	participant	250˙904.00
10	UNIVERSIDAD DE SANTIAGO DE COMPOSTELA UNIVERSIDAD DE SANTIAGO DE COMPOSTELA Organization address address: COLEXIO DE SAN XEROME PRAZA DO OBRADOIRO S/N city: SANTIAGO DE COMPOSTELA postcode: 15782 website: http://www.usc.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (SANTIAGO DE COMPOSTELA)	participant	250˙904.00

Map

Project objective

Although recent advances in nanotechnology have provided an excellent platform to revolutionize the domain of health, the efficient and target delivery of many potent drugs in the body still remains an important challenge due to important drawbacks either from the drug (bioavailability, toxicity, etc.) and/or from the nanocarrier (biocompatibility, reproducibility, insufficient targeting). Consequently, there is currently a real demand for drug nanocarriers able to solve these matters for the different administration routes. HeatNMof project aims to develop smart multifunctional nanocarriers of challenging antitumoral drugs based on versatile highly porous biocompatible nanometric Metal Organic Frameworks, associated with exceptional drug payloads and controlled releases, and photo- and/or magnetic inorganic nanoparticles, providing both a specific control of reactions inside living entities (i.e. heating-triggered drug release) and additional properties such as imaging (magnetic resonance, thermal or optoacoustic imaging) and/ or hyperthermia therapy. The successful development of this project, involving academic and industrial partners, will contribute to the improvement of the highly societal relevant cancer therapy. This research objective is strongly related with the prime training/networking aim of HeatNMof: to train the next generation of materials scientists in a highly interdisciplinary and intersectorial research environment, such that they can soundly address upcoming challenges concerning nanomedicine, from the development, optimization and (physicochemical and biological) characterization of inorganic and hybrid materials, as well as their interaction with living entities, with a strong focus on drug delivery platforms based on nanomaterials. HeatNMof will train the next generation of material scientists with sound expertise in nanomedicine, highly needed to bring advanced materials as proposed from the bench to society.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEATNMOF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEATNMOF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More

HeatNMof (2020)

Heating triggered drug release from nanometric inorganic-metal organic framework composites

Read More